Washington Trust Advisors, Inc. Greenwich Life Sciences, Inc. Transaction History
Washington Trust Advisors, Inc.
- $1.13 Billion
- Q3 2024
A detailed history of Washington Trust Advisors, Inc. transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 200 shares of GLSI stock, worth $2,688. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$2,688
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GLSI
# of Institutions
35Shares Held
1.01MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$4.15 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA268KShares$3.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA128KShares$1.72 Million0.0% of portfolio
-
Credit Agricole S A87KShares$1.17 Million0.01% of portfolio
-
State Street Corp Boston, MA68.4KShares$919,3360.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $173M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...